Rabo Corporate Venturing — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
TripleBar Bio, Inc.triplebar.comin𝕏Oct 2023
Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics.
AI & Machine LearningBiotechDeep TechEmeryville, US
Jeremy Agresti(Founder)inHoward Levin(Director)Maria Cho(Executive Officer, Director)
BoardRose Wardle(Director)David Friedberg(Director)in
Co-investorsiSelect FundStray Dog CapitalSynthesis CapitalTPB
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





